Skip to main content
Erschienen in: Diabetologia 12/2011

01.12.2011 | Short Communication

Do men develop type 2 diabetes at lower body mass indices than women?

verfasst von: J. Logue, J. J. Walker, H. M. Colhoun, G. P. Leese, R. S. Lindsay, J. A. McKnight, A. D. Morris, D. W. Pearson, J. R. Petrie, S. Philip, S. H. Wild, N. Sattar, on behalf of The Scottish Diabetes Research Network Epidemiology Group

Erschienen in: Diabetologia | Ausgabe 12/2011

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

To describe the associations between age, sex and BMI at diagnosis of type 2 diabetes, and test the hypothesis that men are diagnosed with diabetes at lower average BMI than women of similar age.

Methods

Linear regression was used to estimate and compare the relationship between age and BMI at diagnosis among 51,920 men and 43,137 women included in a population-based diabetes register in Scotland for whom an index BMI measurement was taken within 1 year of diabetes diagnosis. We also examined HbA1c values by sex within the same timescale.

Results

Mean BMI closest to date of diagnosis of type 2 diabetes mellitus was 31.83 kg/m2 (SD 5.13) in men and 33.69 kg/m2 (SD 6.43) in women. The inverse relationship between age and BMI at diagnosis of type 2 diabetes mellitus was significantly steeper in women than in men (slope estimate in men −0.12 kg/m2 per year [95% CI −0.13, −0.12] women −0.18 kg/m2 per year [95% CI −0.18, −0.17], p < 0.0001 for formal test of interaction). Mean BMI difference was most marked at younger ages and narrowed with advancing age. However, HbA1c levels within 1 year of diagnoses were broadly similar in men and women.

Conclusions/interpretation

Men are diagnosed with type 2 diabetes at lower BMI than women across the age range. This observation may help explain why type 2 diabetes is more common among middle-aged men in populations of European extraction. Whether the same pattern is also observed in other ethnic groups requires confirmation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Hillier TA, Pedula KL (2001) Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care 24:1522–1527PubMedCrossRef Hillier TA, Pedula KL (2001) Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care 24:1522–1527PubMedCrossRef
2.
Zurück zum Zitat Lipscombe LL, Hux JE (2007) Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study. Lancet 369:750–756PubMedCrossRef Lipscombe LL, Hux JE (2007) Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study. Lancet 369:750–756PubMedCrossRef
3.
Zurück zum Zitat Choi YJ, Kim HC, Kim HM, Park SW, Kim J, Kim DJ (2009) Prevalence and management of diabetes in Korean adults: Korea National Health and Nutrition Examination Surveys 1998–2005. Diabetes Care 32:2016–2020PubMedCrossRef Choi YJ, Kim HC, Kim HM, Park SW, Kim J, Kim DJ (2009) Prevalence and management of diabetes in Korean adults: Korea National Health and Nutrition Examination Surveys 1998–2005. Diabetes Care 32:2016–2020PubMedCrossRef
4.
Zurück zum Zitat Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SR et al (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375:2215–2222, Erratum in: Lancet. 2010;376:958. Hillage, H L [corrected to Hillege, H L]PubMedCrossRef Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SR et al (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375:2215–2222, Erratum in: Lancet. 2010;376:958. Hillage, H L [corrected to Hillege, H L]PubMedCrossRef
5.
Zurück zum Zitat Geer EB, Shen W (2009) Gender differences in insulin resistance, body composition, and energy balance. Gend Med 6(Suppl 1):60–75PubMedCrossRef Geer EB, Shen W (2009) Gender differences in insulin resistance, body composition, and energy balance. Gend Med 6(Suppl 1):60–75PubMedCrossRef
6.
Zurück zum Zitat Emerging Risk Factors Collaboration, Di Angelantonio E, Sarwar N, Perry P et al (2009) Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302:1993–2000PubMedCrossRef Emerging Risk Factors Collaboration, Di Angelantonio E, Sarwar N, Perry P et al (2009) Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302:1993–2000PubMedCrossRef
7.
Zurück zum Zitat Lovejoy JC, Sainsbury A, Stock Conference 2008 Working Group (2008) Sex differences in obesity and the regulation of energy homeostasis. Obes Rev 2009(10):154–167 Lovejoy JC, Sainsbury A, Stock Conference 2008 Working Group (2008) Sex differences in obesity and the regulation of energy homeostasis. Obes Rev 2009(10):154–167
8.
Zurück zum Zitat Knowler WC, Barrett-Connor E, Fowler SE, Diabetes Prevention Program Research Group et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403PubMedCrossRef Knowler WC, Barrett-Connor E, Fowler SE, Diabetes Prevention Program Research Group et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403PubMedCrossRef
9.
Zurück zum Zitat Wannamethee SG, Papacosta O, Whincup PH et al (2010) Assessing prediction of diabetes in older adults using different adiposity measures: a 7 year prospective study in 6,923 older men and women. Diabetologia 53:890–898PubMedCrossRef Wannamethee SG, Papacosta O, Whincup PH et al (2010) Assessing prediction of diabetes in older adults using different adiposity measures: a 7 year prospective study in 6,923 older men and women. Diabetologia 53:890–898PubMedCrossRef
10.
Zurück zum Zitat Wannamethee SG, Papacosta O, Lawlor DA et al (2011) Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than do men? The British Regional Heart Study and British Women’s Heart Health Study. Diabetologia doi:10.1007/s00125-011-2284-4 Wannamethee SG, Papacosta O, Lawlor DA et al (2011) Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than do men? The British Regional Heart Study and British Women’s Heart Health Study. Diabetologia doi:10.​1007/​s00125-011-2284-4
Metadaten
Titel
Do men develop type 2 diabetes at lower body mass indices than women?
verfasst von
J. Logue
J. J. Walker
H. M. Colhoun
G. P. Leese
R. S. Lindsay
J. A. McKnight
A. D. Morris
D. W. Pearson
J. R. Petrie
S. Philip
S. H. Wild
N. Sattar
on behalf of The Scottish Diabetes Research Network Epidemiology Group
Publikationsdatum
01.12.2011
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 12/2011
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-011-2313-3

Weitere Artikel der Ausgabe 12/2011

Diabetologia 12/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.